Risk factors for myelodysplastic syndromes: a case-control study in Greece

被引:53
作者
Dalamaga, M
Petridou, E
Cook, FE
Trichopoulos, D
机构
[1] Univ Athens, Sch Med, Dept Hyg & Epidemiol, GR-11527 Athens, Greece
[2] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA
关键词
Greece; myelodysplastic syndromes; risk factor;
D O I
10.1023/A:1019573319803
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: The etiology of most cases of myelodysplastic syndromes (MDS) has not been elucidated. We have undertaken an investigation in Greece to determine the risk profile of adult de-novo MDS. Methods: A case-control investigation was conducted in a large Veterans' hospital over a five-year period, covering 84 MDS cases and 84 age- and gender-matched controls with minor non-neoplastic non-infectious conditions from the same study base. Cases and controls reported to the medically trained principal investigator lifestyle characteristics and medical histories, with emphasis on autoimmune disorders and allergic conditions. Results: Alcohol intake and tobacco smoking jointly increased significantly the risk of MDS (odd ratio contrasting ever smokers and regular drinkers of at least one glass per day to never smokers and drinkers of less than one glass per day: 9.54, 95% CI 3.52-25.82) whereas each of these factors alone had limited effect. There was also evidence that autoimmune conditions, but not allergic disorders, were positively associated with MDS risk, irrespective of their occurrence during the recent (less than ten years) or the remote (more than ten years) past (OR 3.34, 95% CI 1.15-9.74; OR 3.50, 95% CI 1.19-10.26, respectively). Conclusion: We found evidence that both exogenous and endogenous factors may play a role in the etiology of the so-called "de novo" myelodysplastic syndromes, but these findings need further confirmation.
引用
收藏
页码:603 / 608
页数:6
相关论文
共 28 条
[1]   Smoking and the risk of leukemia, lymphoma, and multiple myeloma (Sweden) [J].
Adami, J ;
Nyren, O ;
Bergstrom, R ;
Ekbom, A ;
Engholm, G ;
Englund, A ;
Glimelius, B .
CANCER CAUSES & CONTROL, 1998, 9 (01) :49-56
[2]  
AHMAD YH, 1995, CANCER, V76, P869, DOI 10.1002/1097-0142(19950901)76:5<869::AID-CNCR2820760522>3.0.CO
[3]  
2-I
[4]   Increasing incidence of myelodysplastic syndromes: Real or fictitious? [J].
Aul, C ;
Germing, U ;
Gattermann, N ;
Minning, H .
LEUKEMIA RESEARCH, 1998, 22 (01) :93-100
[5]   AGE-RELATED INCIDENCE AND OTHER EPIDEMIOLOGIC ASPECTS OF MYELODYSPLASTIC SYNDROMES [J].
AUL, C ;
GATTERMANN, N ;
SCHNEIDER, W .
BRITISH JOURNAL OF HAEMATOLOGY, 1992, 82 (02) :358-367
[6]  
BENNETT JM, 1982, BRIT J HAEMATOL, V51, P189, DOI 10.1111/j.1365-2141.1982.tb08475.x
[7]  
BERIS P, 1989, SEMIN HEMATOL, V26, P216
[8]   Smoking and myelodysplastic syndromes [J].
Björk, J ;
Albin, M ;
Mauritzson, N ;
Strömberg, U ;
Johansson, B ;
Hagmar, L .
EPIDEMIOLOGY, 2000, 11 (03) :285-291
[9]   PRELEUKEMIC ACUTE HUMAN LEUKEMIA [J].
BLOCK, M ;
JACOBSON, LO ;
BETHARD, WF .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1953, 152 (11) :1018-1028
[10]  
Breslow NE, 1980, IARC SCI PUBLICATION, V32